Physician profile
Frederick J Barnes
NPI 1952303521
$1,030.68
in general payments reported to CMS, 2019-2025
13 companies · $126 in 2025
The $126 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $38.97 · 2021: $50.22 · 2022: $237 · 2023: $334 · 2024: $72.77 · 2025: $126.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $533.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $533.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $269.32 | 2022-2023 | Infinion 16 |
| Endo Pharmaceuticals INC. | $192.33 | 2022-2024 | Xiaflex |
| Allergan, INC. | $128.81 | 2019-2020 | |
| Depuy Synthes Sales INC. | $126.98 | 2019-2025 | Monovisc, Orthovisc |
| Horizon Therapeutics Plc | $53.72 | 2020-2022 | |
| Bioventus LLC | $52.07 | 2024-2025 | Durolane, Xcell |
| Ossur Americas, INC. | $49.18 | 2025 | Unloader One X |
| Omeros Corporation | $36.89 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $33.75 | 2023 | Exparel, Zilretta, Iovera |
| Ferring Pharmaceuticals INC. | $29.11 | 2022-2023 | Euflexxa |
| Ermi LLC | $21.14 | 2019 | |
| Sanofi-Aventis U.S. LLC | $18.94 | 2019 | |
| Organogenesis INC. | $18.44 | 2025 | Nushield |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Frederick Barnes listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.